Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BrightSpring Health Services, Inc.BTSG · Entity 3469 | Director | May 05, 2026 | May 07, 2026 |
| GMR Solutions Inc.GMRS · Entity 5222 | Director | August 26, 2026 | August 28, 2026 |
| MiniMed Group, Inc.MMED · Entity 3758 | Director | October 09, 2026 | October 13, 2026 |
| Pear Therapeutics, Inc.PEAR · Entity 114512 | Director | February 15, 2023 | February 17, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BrightSpring Health Services, Inc.
Report date May 05, 2026 · Filed May 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 25,504 |
Reported balance
After 2026-05-05 transaction · row 1
1 source rowRow 1 · 2026-05-05 · Grant · Acquired 4,983 · Balance 25,504 F1: On May 5, 2026, the Reporting Person was granted restricted stock units ("RSUs") which fully vest on May 5, 2027. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The Reporting Person has elected to defer settlement of the RSUs under the terms of the Issuer's Non-Employee Director Deferred Compensation Plan. Settlement of the RSUs shall be in accordance with the Reporting Person's deferral election form to occur either (1) following the Reporting Person's termination of service from the board of directors or (2) on a future date selected by the Reporting Person at the time of their deferral election. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 5, 2026, the Reporting Person was granted restricted stock units ("RSUs") which fully vest on May 5, 2027. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The Reporting Person has elected to defer settlement of the RSUs under the terms of the Issuer's Non-Employee Director Deferred Compensation Plan. Settlement of the RSUs shall be in accordance with the Reporting Person's deferral election form to occur either (1) following the Reporting Person's termination of service from the board of directors or (2) on a future date selected by the Reporting Person at the time of their deferral election.
GMR Solutions Inc.
Report date August 26, 2026 · Filed August 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 976 |
Reported balance
After 2026-08-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-26 · Grant · Acquired 976 · Balance 976 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer Class A common stock ("Class A Common Stock"). The RSUs will be settled in either Class A Common Stock or cash (or a combination thereof) at the Issuer's discretion. F2: These RSUs vest on the earlier of (i) July 1, 2027 and (ii) the first regularly scheduled annual meeting of the stockholders of the Issuer following the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer Class A common stock ("Class A Common Stock"). The RSUs will be settled in either Class A Common Stock or cash (or a combination thereof) at the Issuer's discretion.
F2: These RSUs vest on the earlier of (i) July 1, 2027 and (ii) the first regularly scheduled annual meeting of the stockholders of the Issuer following the date of grant.
MiniMed Group, Inc.
Report date October 09, 2026 · Filed October 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 25,684 |
Reported balance
After 2026-10-09 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-09 · Grant · Acquired 11,795 · Balance 25,684 F1: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the one-year anniversary of the grant date. F2: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the one-year anniversary of the grant date.
F2: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs.
Pear Therapeutics, Inc.
Report date February 15, 2023 · Filed February 17, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 52,380 |
Reported balance
After 2023-02-15 transaction · row 1
1 source rowRow 1 · 2023-02-15 · Grant · Acquired 52,380 · Balance 52,380 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 09, 2026 Filed Oct 13, 2026 22:14 UTC | MiniMed Group, Inc. MMED · Entity 3758 | GrantCommon Stock | 11,795 | $0.00 | $0.00 |
DisclosureSEC source: 0001339919-26-000002 · wk-form4_1791929660.xml · nonDerivative · entry 1 Wicks Timothy A · CIK 0001339919 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,684 F1 · shares: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the one-year anniversary of the grant date. F2 · balance_after: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs. Read SEC document |
| August 26, 2026 Filed Aug 28, 2026 17:16 UTC | GMR Solutions Inc. GMRS · Entity 5222 | GrantRestricted Stock Units · Derivative | 976 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-103329 · tm2624312-4_4seq1.xml · derivative · entry 1 Wicks Timothy A · CIK 0001339919 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 976 Underlying: Class A Common Stock · 976 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer Class A common stock ("Class A Common Stock"). The RSUs will be settled in either Class A Common Stock or cash (or a combination thereof) at the Issuer's discretion. F2 · derivative.exercise_date: These RSUs vest on the earlier of (i) July 1, 2027 and (ii) the first regularly scheduled annual meeting of the stockholders of the Issuer following the date of grant. F2 · derivative.expiration_date: These RSUs vest on the earlier of (i) July 1, 2027 and (ii) the first regularly scheduled annual meeting of the stockholders of the Issuer following the date of grant. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:34 UTC | GMR Solutions Inc. GMRS · Entity 5222 | GrantRestricted Stock Units · Derivative | 12,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-062662 · tm2614730-3_4seq1.xml · derivative · entry 1 Wicks Timothy A · CIK 0001339919 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,334 Underlying: Class A Common Stock · 12,334 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer Class A common stock ("Class A Common Stock"). The RSUs will be settled in either Class A Common Stock or cash (or a combination thereof) at the Issuer's discretion. F2 · derivative.exercise_date: These RSUs vest on the earlier of (i) May 12, 2027 and (ii) the first regularly scheduled annual meeting of the stockholders of the Issuer following the date of grant. F2 · derivative.expiration_date: These RSUs vest on the earlier of (i) May 12, 2027 and (ii) the first regularly scheduled annual meeting of the stockholders of the Issuer following the date of grant. Read SEC document |
| May 05, 2026 Filed May 7, 2026 22:30 UTC | BrightSpring Health Services, Inc. BTSG · Entity 3469 | GrantCommon Stock | 4,983 | $0.00 | $0.00 |
DisclosureSEC source: 0000908834-26-000215 · form4.xml · nonDerivative · entry 1 Wicks Timothy A · CIK 0001339919 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,504 F1 · kind: On May 5, 2026, the Reporting Person was granted restricted stock units ("RSUs") which fully vest on May 5, 2027. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The Reporting Person has elected to defer settlement of the RSUs under the terms of the Issuer's Non-Employee Director Deferred Compensation Plan. Settlement of the RSUs shall be in accordance with the Reporting Person's deferral election form to occur either (1) following the Reporting Person's termination of service from the board of directors or (2) on a future date selected by the Reporting Person at the time of their deferral election. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 20:31 UTC | MiniMed Group, Inc. MMED · Entity 3758 | GrantCommon Stock | 13,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-016857 · wk-form4_1773261080.xml · nonDerivative · entry 1 Wicks Timothy A · CIK 0001339919 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,889 F1 · shares: Represents restricted stock units that vest on the one-year anniversary of the grant date. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| May 05, 2025 Filed May 7, 2025 20:10 UTC | BrightSpring Health Services, Inc. BTSG · Entity 3469 | GrantCommon Stock | 11,912 | $0.00 | $0.00 |
DisclosureSEC source: 0000908834-25-000146 · form4.xml · nonDerivative · entry 1 Wicks Timothy A · CIK 0001339919 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,521 F1 · kind: On May 5, 2025, the Reporting Person was granted restricted stock units ("RSUs") which fully vest on May 5, 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The Reporting Person has elected to defer settlement of the RSUs under the terms of the Company's Non-Employee Director Deferred Compensation Plan. Settlement of the RSUs shall be in accordance with the Reporting Person's deferral election form to occur either (1) following the Reporting Person's termination of service from the board of directors or (2) on a future date selected by the Reporting Person at the time of their deferral election. F2 · balance_after: Includes 11,912 shares of the Issuer's common stock underlying RSUs, as described in footnote 1 herein. Read SEC document |
| May 03, 2025 Filed May 6, 2025 20:01 UTC | BrightSpring Health Services, Inc. BTSG · Entity 3469 | Tax withholdingCommon Stock | 7,044 | $20.87 | $147,008.28 |
DisclosureSEC source: 0000908834-25-000139 · form4.xml · nonDerivative · entry 1 Wicks Timothy A · CIK 0001339919 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,609 F1 · shares: Represents shares of the Issuer's common stock withheld by the Issuer to satisfy withholding taxes due in connection with the vesting of 15,653 restricted stock units at a net settlement price equal to the closing stock price on May 3, 2025. Read SEC document |
| May 03, 2024 Filed May 7, 2024 21:10 UTC | BrightSpring Health Services, Inc. BTSG · Entity 3469 | GrantCommon Stock | 15,653 | $0.00 | $0.00 |
DisclosureSEC source: 0000908834-24-000122 · form4.xml · nonDerivative · entry 1 Wicks Timothy A · CIK 0001339919 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,653 F1 · kind: On May 3, 2024, the Reporting Person was granted restricted stock units ("RSUs") which fully vest on May 3, 2025. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. F2 · balance_after: Includes 15,653 shares of the Issuer's common stock underlying RSUs, as described in footnote 1 herein. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 21:12 UTC | Pear Therapeutics, Inc. PEAR · Entity 114512 | GrantClass A Common Stock | 52,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-004037 · form4.xml · nonDerivative · entry 1 Wicks Timothy A · CIK 0001339919 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,380 Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:12 UTC | Pear Therapeutics, Inc. PEAR · Entity 114512 | GrantRestricted Stock Units · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-014972 · form4.xml · derivative · entry 2 Wicks Timothy A · CIK 0001339919 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Class A Common Stock · 100,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PEAR common stock. F3 · derivative.exercise_date: The restricted stock units shall vest and settle as to 100% of the shares on the Separation Date, provided that the Separation Date occurs on or after June 14, 2023 (and for the avoidance of doubt, if the Separation Date occurs prior to June 14, 2023, the restricted stock units shall expire unvested). F3 · derivative.expiration_date: The restricted stock units shall vest and settle as to 100% of the shares on the Separation Date, provided that the Separation Date occurs on or after June 14, 2023 (and for the avoidance of doubt, if the Separation Date occurs prior to June 14, 2023, the restricted stock units shall expire unvested). Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:12 UTC | Pear Therapeutics, Inc. PEAR · Entity 114512 | GrantRestricted Stock Units · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-014972 · form4.xml · derivative · entry 1 Wicks Timothy A · CIK 0001339919 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Class A Common Stock · 100,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PEAR common stock. F2 · derivative.exercise_date: The restricted stock units shall vest and settle (x) as to 100% of the shares upon the Reporting Person's cessation of Service Relationship (as defined in the Issuer's 2021 Stock Option and Incentive Plan) that qualifies as a "separation from service" within the meaning of Section 409A of the Internal Revenue Code (the "Separation Date"), provided that the Separation Date occurs on or after June 14, 2025 or (y) if the Separation Date occurs prior to June 14, 2025, the restricted stock units shall vest and settle only as to the percentage of the shares equal to the product of (a) the number of twelve month periods between the grant date and the Separation Date multiplied by (b) 33.33 1/3 (and for the avoidance of doubt, if the Separation Date occurs prior to June 14, 2023, the restricted stock units shall expire unvested). F2 · derivative.expiration_date: The restricted stock units shall vest and settle (x) as to 100% of the shares upon the Reporting Person's cessation of Service Relationship (as defined in the Issuer's 2021 Stock Option and Incentive Plan) that qualifies as a "separation from service" within the meaning of Section 409A of the Internal Revenue Code (the "Separation Date"), provided that the Separation Date occurs on or after June 14, 2025 or (y) if the Separation Date occurs prior to June 14, 2025, the restricted stock units shall vest and settle only as to the percentage of the shares equal to the product of (a) the number of twelve month periods between the grant date and the Separation Date multiplied by (b) 33.33 1/3 (and for the avoidance of doubt, if the Separation Date occurs prior to June 14, 2023, the restricted stock units shall expire unvested). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.